These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22562987)

  • 1. Early FDG/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancer.
    Krystal GW; Alesi E; Tatum JL
    Mol Cancer Ther; 2012 Jul; 11(7):1385-8. PubMed ID: 22562987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial.
    Berger AK; von Gall C; Abel U; Delorme S; Kloor M; Ose J; Weber TF; Stange A; Haag GM; Haberkorn U; Lordick F; Jäger D
    BMC Cancer; 2012 Mar; 12():108. PubMed ID: 22439666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'-Deoxy-3'-
    Kim JE; Chae SY; Kim JH; Kim HJ; Kim TW; Kim KP; Kim SY; Lee JL; Oh SJ; Kim JS; Ryu JS; Moon DH; Hong YS
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1713-1722. PubMed ID: 31041456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
    Goshen E; Davidson T; Zwas ST; Aderka D
    Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early
    Skougaard K; Nielsen D; Jensen BV; Pfeiffer P; Hendel HW
    Acta Oncol; 2016; 55(9-10):1175-1182. PubMed ID: 27548393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab.
    Seront E; Marot L; Coche E; Gala JL; Sempoux C; Humblet Y
    Cancer Treat Rev; 2010 Feb; 36 Suppl 1():S11-4. PubMed ID: 20189054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.
    Tol J; Punt CJ
    Clin Ther; 2010 Mar; 32(3):437-53. PubMed ID: 20399983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.
    Jean GW; Shah SR
    Pharmacotherapy; 2008 Jun; 28(6):742-54. PubMed ID: 18503402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Preoperative ¹⁸F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer.
    Choi YJ; Kim MJ; Lee BH; Kwon MJ; Hwang HS
    Yonsei Med J; 2016 Jan; 57(1):232-7. PubMed ID: 26632406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prediction by 18F-FDG PET/CT for progression-free survival and overall survival in patients with metastatic colorectal cancer receiving third-line cetuximab-based therapy.
    Liu FY; Yen TC; Wang JY; Yang TS
    Clin Nucl Med; 2015 Mar; 40(3):200-5. PubMed ID: 25608159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panitumumab: an arrow on target.
    Kopper L
    Pathol Oncol Res; 2010 Jun; 16(2):143-8. PubMed ID: 20432075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 100% human monoclonal antibodies in oncology: hype or breakthrough?
    Benay S; Fanciullino R; Mercier C; Iliadis A; Ciccolini J; Lacarelle B
    Curr Top Med Chem; 2012; 12(15):1643-8. PubMed ID: 22978333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
    Arslan C; Kilickap S
    Ann Oncol; 2009 Jun; 20(6):1149-50; author reply 1150. PubMed ID: 19465432
    [No Abstract]   [Full Text] [Related]  

  • 14. FDG PET/CT evaluation of treatment response in patients with recurrent colorectal cancer.
    Shamim SA; Kumar R; Shandal V; Halanaik D; Kumar G; Bal CS; Malhotra A
    Clin Nucl Med; 2011 Jan; 36(1):11-6. PubMed ID: 21157200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer.
    Lin EH; Lenz HJ; Saleh MN; Mackenzie MJ; Knost JA; Pathiraja K; Langdon RB; Yao SL; Lu BD
    Cancer Med; 2014 Aug; 3(4):988-97. PubMed ID: 24905030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype.
    Groheux D; Majdoub M; Sanna A; de Cremoux P; Hindié E; Giacchetti S; Martineau A; de Roquancourt A; Merlet P; Visvikis D; Resche-Rigon M; Hatt M; Espié M
    Radiology; 2015 Nov; 277(2):358-71. PubMed ID: 25915099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.
    Hendlisz A; Golfinopoulos V; Garcia C; Covas A; Emonts P; Ameye L; Paesmans M; Deleporte A; Machiels G; Toussaint E; Vanderlinden B; Awada A; Piccart M; Flamen P
    Ann Oncol; 2012 Jul; 23(7):1687-93. PubMed ID: 22112970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panitumumab in colorectal cancer.
    Wainberg ZA; Hecht JR
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):967-73. PubMed ID: 17627455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer.
    Hecht JR; Patnaik A; Berlin J; Venook A; Malik I; Tchekmedyian S; Navale L; Amado RG; Meropol NJ
    Cancer; 2007 Sep; 110(5):980-8. PubMed ID: 17671985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives.
    Battaglin F; Dadduzio V; Bergamo F; Manai C; Schirripa M; Lonardi S; Zagonel V; Loupakis F
    Expert Opin Biol Ther; 2017 Oct; 17(10):1297-1308. PubMed ID: 28752777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.